Zami Aberman, CEO & Chairman at PLURISTEM THERAPEUTICS INC (PSTI), bought 31,000 shares at $0.80 ($25K) on 2016-02-11, disclosed to the SEC on 2016-02-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PSTI | BUY | 2019-04-08 | $100K | — | Filing → |
| PSTI | BUY | 2016-02-24 | $7K | — | Filing → |
| PSTI | BUY | 2016-02-17 | $16K | — | Filing → |